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 Diabetes, the seventh leading cause of death 
in the United States, is caused by excessive blood 
glucose.1 Type 1 diabetes is a variation of the disease 
characterized by a deficiency in insulin, a hormone 
produced in the pancreas that allows cells to take up 
glucose from the blood and receive energy. Lack of 
insulin results in accumulation of sugar in the blood-
stream, and subsequently dehydration, excessive 
urination, and tissue damage.2 The need to prevent the 
disease is urgent, as over a million children or young 
adults in the world have type 1 diabetes, and over 
100,000 cases of type 1 diabetes are diagnosed every 
year.3 Type 1 diabetes is known as 
an autoimmune disease because 
the immune system destroys in-
sulin-producing beta cells in the 
pancreas.2 What is not certain is the 
mechanism by which this occurs. 
However, recent research has linked 
the disease to a newly found cell 
called the X lymphocyte.4
 We are familiar with the B 
and T lymphocytes, which are 
involved in the acquired immune response in our 
bodies for fighting against extracellular pathogens. B 
cells function to secrete antibodies that recognize an-
tigens and are involved in humoral immunity. During 
maturation in the bone marrow, B cells that react 
with self-antigens are negatively selected; that is, they 
undergo apoptosis or receptor modification so that 
they are not a threat to the body. The surviving B cells 
then travel to the spleen to complete maturation and 
become naive B cells, which are mature cells that are 
not yet activated.5 T cells arrive in different classes and 
fight against intracellular pathogens through cell-me-
diated immunity. During maturation in the thymus, 
, T cells also undergo negative selection, and once ma-
tured, are known as naive T cells.6
 Antigen-presenting cells (APCs) recognize 
protein antigens and display them to T cells. A B cell 
can act as an APC and recognize protein antigens us-
ing its B-cell receptor (BCR) to internalize the antigen 
and process and display the antigen on an MHC II 
molecule. A helper T cell can recognize the present-
ed antigen through its T-cell receptor (TCR), and the 
interaction between the MHC II on the B cell and CD4 
molecule on the T cell results in T cell activation. The 
T cell secretes cytokines that activate the B cell, which
differentiates into plasma cells that se-
crete antibodies and memory cells that 
remain for future invaders.5 Cytotoxic 
T cells, unlike helper T cells, directly 
target pathogen-infected cells and de-
stroy the cells along with the pathogen 
inside.6
 Normally, the only two types 
of lymphocytes that the body produc-
es are B and T lymphocytes. What is 
previously known regarding the 
mechanism of insulin destruction is that insulin can 
bind to a molecule on APCs known as HLA-DQ8. 
However, the binding is not strong enough to trigger 
a reaction that leads to type 1 diabetes. Researchers at 
Johns Hopkins Medicine recently utilized computer 
simulations that revealed dual-expressor (DE) cells 
which express both the BCR and TCR. A protein cod-
ed by the BCR of DE cells, named the x-Id peptide, can 
bind to HLA-DQ8 very tightly compared to insulin, 
and the binding is strong enough to bring out a T cell 
response that can result in type 1 diabetes.4
 To test the strength of the T cell response by 
DE cells, the researchers produced a genetically-
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engineered insulin mimic called the “superagonist,” 
which has a higher affinity for HLA-DQ8 than normal 
insulin and is 1,000 times more immune-stimulating. 
The team ran computer simulations which illustrated 
that the x-Id protein resulted in a T cell response with 
tenfold increased strength over that of the superag-
onist; hence, the x-Id protein displayed a trigger in 
T cell activity that is 10,000 times stronger than that 
produced by normal insulin. These results suggest that 
the x-Id protein found in DE cells can elicit strong T 
cell responses that can then attack insulin-producing 
cells.4, 7 
 To confirm the existence of the DE cell, which 
can be referred to as the “X” lymphocyte, the research-
ers used a virus to produce genetically-identical dupli-
cates of the cell, and found that the clone cells all ex-
pressed both BCRs and TCRs, illustrating that the cell 
is a hybrid of the B cell and the T cell. Furthermore, 
the researchers obtained blood samples from donors 
with type 1 diabetes and healthy donors and found that 
the DE lymphocytes appeared more frequently in pa-
tients with type 1 diabetes than nondiabetic subjects.4, 
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 The discovery of the X lymphocyte helps 
deepen our understanding of type 1 diabetes and can 
be insightful for those searching for a cure for the 
condition. While the results of the X lymphocyte study 
at Johns Hopkins yields valuable information, more 
studies should be done to further confirm and analyze 
the new type of cell. In the future, more information 
regarding the X lymphocyte and its behavior can bring 
us closer to finding a cure for type 1 diabetes. 
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